4/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: February 25, 2015
Period of Report: December 31, 2014
Accession Number: 0000886163-15-000030

View Document ↗ View on SEC.gov ↗